期刊
ACS CENTRAL SCIENCE
卷 6, 期 10, 页码 1800-1812出版社
AMER CHEMICAL SOC
DOI: 10.1021/acscentsci.0c00732
关键词
-
资金
- Center for Human Systems Immunology
- Bill & Melinda Gates Foundation [OPP1113682, OPP1211043]
- National Cancer Institute [1R01CA219994]
- Stanford Institute for Immunity, Transplantation Infection
- National Science Foundation [ECCS-1542152]
- Stanford High Throughput Bioscience Center (HTBC)
- Bill and Melinda Gates Foundation [OPP1211043] Funding Source: Bill and Melinda Gates Foundation
Vaccines aim to elicit a robust, yet targeted, immune response. Failure of a vaccine to elicit such a response arises in part from inappropriate temporal control over antigen and adjuvant presentation to the immune system. In this work, we sought to exploit the immune system's natural response to extended pathogen exposure during infection by designing an easily administered slow-delivery vaccine platform. We utilized an injectable and self-healing polymer-nanoparticle (PNP) hydrogel platform to prolong the codelivery of vaccine components to the immune system. We demonstrated that these hydrogels exhibit unique delivery characteristics, whereby physicochemically distinct compounds (such as antigen and adjuvant) could be codelivered over the course of weeks. When administered in mice, hydrogel-based sustained vaccine exposure enhanced the magnitude, duration, and quality of the humoral immune response compared to standard PBS bolus administration of the same model vaccine. We report that the creation of a local inflammatory niche within the hydrogel, coupled with sustained exposure of vaccine cargo, enhanced the magnitude and duration of germinal center responses in the lymph nodes. This strengthened germinal center response promoted greater antibody affinity maturation, resulting in a more than 1000-fold increase in antigen-specific antibody affinity in comparison to bolus immunization. In summary, this work introduces a simple and effective vaccine delivery platform that increases the potency and durability of subunit vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据